Faith-based workshops aim to boost cancer screening in muslim women
NCT ID NCT06106165
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a two-hour, peer-led workshop with religious messages could encourage Muslim women in North East England and Scotland to get screened for breast, bowel, and cervical cancer. 169 women aged 25-74 who were not up-to-date with all eligible screenings took part. The goal was to see if the approach is feasible and acceptable, not yet to prove it works. Results will inform a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- peer-led faith-based workshop
- What this could lead to
- If successful, this approach could help increase cancer screening rates among Muslim women, potentially leading to earlier detection and better health outcomes.
- What could go wrong
- This is a small feasibility study, not a full trial. It may not show a clear benefit, and results may not apply to other groups or regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BOWEL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Glasgow
Glasgow, Scotland, United Kingdom
-
University of Sunderland
Sunderland, Tyne and Wear, SR1 3SD, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a new drug combo revive Immunotherapy's power against resistant tumors?